Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Century Sage Scientific Holdings Ltd ( (HK:1450) ) just unveiled an update.
Be Friends Holding Limited reported consolidated revenue of RMB1.55 billion for 2025, up 23.8% from the previous year, driven mainly by steady expansion of its Matrix Live Channel. Net profit rose 21.4% to RMB88 million, while adjusted net profit edged down 4.8% to RMB116 million due to changes in the company’s equity and cash incentive program.
Management said China’s live-streaming e-commerce market has entered a slower, more refined growth phase, with rising traffic acquisition costs and more demanding consumers. In response, the group upgraded its strategy to become an AI-driven new retail player, embedding AI across its “content + e-commerce + AI” business system and tightening compliance in product selection, live-stream standards and after-sales, aiming to strengthen its competitive positioning and build trust with consumers and partners.
The most recent analyst rating on (HK:1450) stock is a Buy with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.
More about Century Sage Scientific Holdings Ltd
Be Friends Holding Limited operates in China’s live-streaming e-commerce sector, leveraging platforms such as Douyin and Taobao Live to sell a broad range of consumer products. The group has evolved from personality-driven live streams to a standardized, matrix-style operation, and is repositioning itself as an AI-driven new retail enterprise that integrates content, e-commerce and artificial intelligence to enhance user acquisition, conversion and lifecycle management.
Average Trading Volume: 861,795
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.11B
Find detailed analytics on 1450 stock on TipRanks’ Stock Analysis page.

